에 대한 최신 뉴스 Equifax (NYSE:EFX) 주식

EQUIFAX INC

Equifax

Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.

Consumer,Financial,Protection,Bureau,Text,Written,On,White,Background,With

News

소비자금융보호국(CFPB)은 불공정 금융 관행으로부터 국민을 보호하기 위해 만들어진 정부 기관이며, 현재 임시 국장인 러셀 보우트(Russell Vought)이 대부분의 기능을 중단시켰다. 코인베이스 글로벌(COIN) CEO인 브라이언 암스트롱과 암호화폐 거래소 제미니(Gemini) CEO인 타일러 윙클보스 등 많은 암호화폐 업계 리더들은 이러한 결정에 매우 만족하고 있다. 

암호화폐 업계 리더들, CFPB 폐쇄에 환호 &#34;그간 미국에 엄청난 피해 입혀&#34;

Red,Stock,Market,Price,Showing,Trader,Phobia,Of,Crisis,War

Movers

ANET

ASML

BRKR

COIN

JBHT

MSTR

TSLA

지난주 이들 11개 대형주는 최하의 성과를 보여주었다. 여러분이 보유한 포트폴리오에도 이들이 있나요? Arm 홀딩스(NASDAQ:ARM)는 지난주 가장 성과가 나쁜 대형주 기업으로 31.08% 폭락했다. 이 회사의 주가는 ASML 홀딩 N.V. (NASDAQ:ASML)이 예상보다 저조한 1분기 연간 실적 발표에 영향을 받았다.

지난주 최하 성과 주식: 이 11개의 대형주가 포트폴리오에 있나요?

Equifax Inc

Effect Network

Enerflex Ltd

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) has outperformed the market over the past 15 years by 3.84% on an annualized basis producing an average annual return of 15.61%. Currently, Equifax has a market capitalization of $32.56 billion. 
Buying $1000 In EFX: If an investor had bought $1000 of EFX stock 15 years ago, it would be worth $8,787.80 today based on a price of $262.14 for EFX at the time of writing.
<h3>Equifax's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748464221_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

<a href="https://www.cnbc.com/live-tv/" title="https://www.cnbc.com/live-tv/">https://www.cnbc.com/live-tv/</a>

FICO

FMCC

FNMA

Live On CNBC FHFA Director Bill Pulte Says: Fannie Mae And Freddie Mac Could Be Worth Trillions of Dollars

<a href="https://x.com/pulte/status/1927362114894585944">https://x.com/pulte/status/1927362114894585944</a>

General

Federal Housing Finance Administration Director Bill Pulte Posts On X "Thanks for input. Still not happy with FICO. We should be making some decisions on all related items in next 1-3 weeks."

Oppenheimer analyst Owen Lau maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Outperform and raises the price target from $277 to $296.

Price Target

Analyst Ratings

Oppenheimer Maintains Outperform on Equifax, Raises Price Target to $296

During the last three months, 5 analysts shared their evaluations of Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Equifax, presenting an average target of $289.0, a high estimate of $306.00, and a low estimate of $260.00. A 5.0% drop is evident in the current average compared to the previous average price target of $304.20. 
<img src="https://www.benzinga.com/files/images/story/2025/1747854059_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Equifax. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$306.00</td>
<td>$288.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$300.00</td>
</tr>
<tr>
<td>Kyle Peterson</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$295.00</td>
<td>$295.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$284.00</td>
<td>$313.00</td>
</tr>
<tr>
<td>Manav Patnaik</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$260.00</td>
<td>$325.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Equifax. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Equifax compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Equifax's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Equifax's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EFX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Equifax analyst ratings.</a>
<h2>About Equifax</h2>
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
<h3>Breaking Down Equifax's Financial Performance</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Equifax's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 3.79%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Equifax's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 9.23%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.72%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Equifax's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.13%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Equifax's debt-to-equity ratio is below the industry average. With a ratio of 1.0, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>How Are Analyst Ratings Determined?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Equifax Stock: Analyst Perspectives (5 Ratings)

<a href="https://newslink.mba.org/mba-newslinks/2025/may/bill-pulte-on-whats-next-for-federal-housing-conservatorship-and-transparency/" title="https://newslink.mba.org/mba-newslinks/2025/may/bill-pulte-on-whats-next-for-federal-housing-conservatorship-and-transparency/">https://newslink.mba.org/mba-newslinks/2025/may/bill-pulte-on-whats-next-for-federal-housing-conservatorship-and-transparency/</a>

Watching Fair Isaac, Equifax, TransUnion; Shares Trading Lower After Federal Housing Finance Administration Director Bill Pulte's Remarks At A Mortgage Bankers Association Conference

Wells Fargo analyst Jason Haas maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and raises the price target from $288 to $306.

Wells Fargo Maintains Overweight on Equifax, Raises Price Target to $306

<a href="https://nationalmortgageprofessional.com/news/moodys-downgrades-fannie-and-freddie-following-us-sovereign-credit-cut" title="https://nationalmortgageprofessional.com/news/moodys-downgrades-fannie-and-freddie-following-us-sovereign-credit-cut">https://nationalmortgageprofessional.com/news/moodys-downgrades-fannie-and-freddie-following-us-sovereign-credit-cut</a>

'Moody's Downgrades Fannie And Freddie Following U.S. Sovereign Credit Cut' - National Mortgage Professional

Earnings

AAOI

ABCL

ABEV

ACIC

ACIW

ACMR

ACTG

AFRM

AKAM

AKBA

ALGM

ALIT

ALRM

ALXO

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

AMPX

AMTX

APPN

APYX

AQMS

ARGX

ARHS

ARKO

ARLO

ASPN

ASTH

Adtalem Global Education Inc. Common Stock

ATGE

ATHM

ATUS

AUTL

AVAH

AVPT

AXGN

BAER

BBDC

BIGC

BILL

BIRD

BlackSky Technology Inc. Class A Common Stock

BKSY

BLFS

BLND

CARG

CARS

CBLL

CBUS

CCEC

CCOI

CCRD

CDTX

CION

CLAR

CLFD

CLNE

CLSK

CMPS

CMRE

CODX

COLD

COLL

COMP

CRNX

CRON

CROX

CRVS

CTEV

CTKB

CTLP

CVRX

DAVE

DCGO

DCTH

DIOD

DKNG

Earnings Scheduled For May 8, 2025

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4417564-1&amp;h=4285159771&amp;u=https%3A%2F%2Fwww.equifax.com%2Fabout-equifax%2Fwho-we-are%2F&amp;a=Equifax">Equifax</a>&#xAE;&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) has introduced a new <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4417564-1&amp;h=1818080364&amp;u=https%3A%2F%2Fwww.equifax.com%2Fapp&amp;a=myEquifax%E2%84%A2+mobile+app">myEquifax&#x2122; mobile app</a><a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4417564-1&amp;h=116206068&amp;u=https%3A%2F%2Fwww.equifax.com%2Fapp&amp;a=lication">lication</a>&nbsp;for <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4417564-1&amp;h=3844420230&amp;u=https%3A%2F%2Fplay.google.com%2Fstore%2Fapps%2Fdetails%3Fid%3Dcom.equifax.myequifax%26hl%3Den_GB&amp;a=Android">Android</a>&#x2122;&nbsp;and <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4417564-1&amp;h=493773581&amp;u=https%3A%2F%2Fapps.apple.com%2Fus%2Fapp%2Fmyequifax%2Fid6502468755&amp;a=iPhone">iPhone</a>&#xAE;, offering consumers a convenient way to monitor their financial health from their mobile devices. In the app, users can directly view their Equifax credit report as well as manage existing credit freezes and fraud alerts.
To access the myEquifax mobile app, consumers can simply download it from the Apple App Store&#xAE;&nbsp;or on Google Play and then use their <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4417564-1&amp;h=3994930924&amp;u=https%3A%2F%2Fmy.equifax.com%2Fmembercenter%2F%23%2Flogin&amp;a=myEquifax">myEquifax</a>&#x2122; account to login. If a user does not have a myEquifax account, they can register for <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4417564-1&amp;h=3603503856&amp;u=https%3A%2F%2Fwww.equifax.com%2Fpersonal%2Fproducts%2Fcredit%2Ffree-credit-score%2F&amp;a=Equifax+Core+Credit">Equifax Core Credit</a>&#x2122;, a free resource that will allow the user to access the mobile app.
The mobile app enables users who sign up with Equifax Core Credit to view their current VantageScore 3.0 credit score and also includes a "My Journey" section that helps consumers set credit score milestones and track their progress over time. Additional app features include the use of biometrics for secure authentication and access to <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4417564-1&amp;h=2777187422&amp;u=https%3A%2F%2Fwww.equifax.com%2Fpersonal%2Feducation%2F&amp;a=Equifax+Knowledge+Center">Equifax Knowledge Center</a> resources where consumers can learn more about how the credit system works. Consumers with a paid subscription will have access to their current features, which may include multi-bureau reports and scores as well as identity restoration services.
"Our Purpose is to help people live their financial best, and providing consumers with the resources they need to increase their financial capability is an important part of that commitment," said Aparna Shah, who leads the Direct to Consumer Business at Equifax. "The new myEquifax mobile app, powered by <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4417564-1&amp;h=1306405099&amp;u=https%3A%2F%2Fwww.equifax.com%2Fabout-equifax%2Fequifax-cloud%2F&amp;a=The+Equifax+Cloud%E2%84%A2">The Equifax Cloud&#x2122;</a>, is designed to help people better understand their current credit position and empower them in their financial lives."
<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4417564-1&amp;h=161856563&amp;u=https%3A%2F%2Fwww.equifax.com%2Fabout-equifax%2Fequifax-cloud%2F&amp;a=The+Equifax+Cloud">The Equifax Cloud</a>&nbsp;is a top-tier global technology and security infrastructure backed by a more than $1.5 billion multi-year investment. The Equifax Cloud is one of the largest Cloud initiatives ever undertaken in the industry, and enables the development of solutions that are faster, more reliable, more powerful, and more secure than ever before.

Equifax Releases myEquifax Mobile Application To Help Consumers Monitor Their Financial Health

RBC Capital analyst Ashish Sabadra reiterates Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Outperform and maintains $300 price target.

Reiteration

RBC Capital Reiterates Outperform on Equifax, Maintains $300 Price Target

During the last three months, 10 analysts shared their evaluations of Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>), revealing diverse outlooks from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $296.3, a high estimate of $325.00, and a low estimate of $260.00. This current average represents a 5.61% decrease from the previous average price target of $313.90. 
<img src="https://www.benzinga.com/files/images/story/2025/1745409702_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of Equifax by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Kyle Peterson &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $295.00&#x7C;$295.00 &#x7C; 
&#x7C;Jason Haas &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $284.00&#x7C;$313.00 &#x7C; 
&#x7C;Manav Patnaik &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $260.00&#x7C;$325.00 &#x7C; 
&#x7C;Manav Patnaik &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $325.00&#x7C;$335.00 &#x7C; 
&#x7C;Owen Lau &#x7C;Oppenheimer &#x7C;Lowers &#x7C;Outperform &#x7C; $279.00&#x7C;$286.00 &#x7C; 
&#x7C;Kevin Mcveigh &#x7C;UBS &#x7C;Lowers &#x7C;Buy &#x7C; $310.00&#x7C;$335.00 &#x7C; 
&#x7C;Shlomo Rosenbaum &#x7C;Stifel &#x7C;Lowers &#x7C;Buy &#x7C; $281.00&#x7C;$284.00 &#x7C; 
&#x7C;Kyle Peterson &#x7C;Needham &#x7C;Lowers &#x7C;Buy &#x7C; $300.00&#x7C;$325.00 &#x7C; 
&#x7C;Jason Haas &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $313.00&#x7C;$321.00 &#x7C; 
&#x7C;Toni Kaplan &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $316.00&#x7C;$320.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Equifax. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Equifax compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Equifax's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Equifax's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EFX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Equifax analyst ratings.</a>
<h2>About Equifax</h2>
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates just over 20% of its revenue from outside the United States.
<h3>Financial Insights: Equifax</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Equifax's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 7.0%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Equifax's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 12.26%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Equifax's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 3.59%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 1.44%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Equifax's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.04.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Equifax: Insights From 10 Analyst Reviews

Needham analyst Kyle Peterson reiterates Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy and maintains $295 price target.

Needham Reiterates Buy on Equifax, Maintains $295 Price Target

After Monday&#8217;s broad-based sell-off — triggered by renewed pressure from President Donald Trump on Federal Reserve Chairman Jerome Powell, raising concerns over the integrity of central bank independence — Wall Street bounced back with strength on Tuesday, buoyed by upbeat signals from <a href="https://www.benzinga.com/earnings">the corporate earnings season.</a>
By midday in New York, major indices were up by nearly 3%, with all 11 sectors of the S&amp;P 500 trading in positive territory. Consumer discretionary stocks led the rally.
The Dow Jones Industrial Average surged over 1,000 points, breaking above the 39,200 mark, as bullish momentum swept across Wall Street. Only a few S&amp;P 500 stocks remained in negative territory.
At a JPMorgan-hosted event in Washington, U.S. Treasury Secretary Scott Bessent hinted at a potential de-escalation in tensions with China, further supporting risk sentiment.
Shares of Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) surged nearly 5% as investors looked ahead to the company's first-quarter earnings report, due after the closing bell.
In the bond market, after two sessions of rising Treasury yields, a modest pullback suggested some investors saw an opportunity to buy as long-dated yields neared the 5% threshold.
On the commodities front, gold briefly touched $3,500 per ounce overnight before retreating to $3,420 amid an improvement in equity market sentiment. Oil jumped 2.3%, with WTI crude reaching $64 per barrel, while copper gained 2.8%.
The cryptocurrency market also reflected a broader risk-on mood. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rallied 4% to $91,000, while Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) advanced more than 7% to $1,700.
<h1 class="wp-block-heading">Tuesday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>Chg</td>
<td>1-day %</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>18,321.10</td>
<td>+512.80</td>
<td>2.9%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>39,215.87</td>
<td>+1,045.46</td>
<td>2.7%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,297.34</td>
<td>+139.14</td>
<td>2.7%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,889.24</td>
<td>+48.92</td>
<td>2.7%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:10 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rallied 2.7% to $527.95.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 3.9% to $392.14.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rose 3% to $446.20.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rallied 2.7% to $187.68.</li>
<li>The&nbsp;Consumer Discretionary&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, up 3.8%. </li>
</ul>
<h1 class="wp-block-heading">Tuesday&#8217;s Stock Movers</h1>
Stocks reacting to quarterly earnings included: 
<ul>
<li>General Electric Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) up 4.8%</li>
<li>Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) up 0.5%,</li>
<li>RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) down 8.7%</li>
<li>Danaher Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) up 6.6%, </li>
<li>Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) up 2.4%, </li>
<li>Moody&#8217;s Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>) up 3%</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) up 8%</li>
<li>Northrop Grumman Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) down 13%</li>
<li>Equifax Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) up 14%. </li>
<li>Halliburton Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) down 4.9%. </li>
</ul>
Shares of First Solar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) soared 12% as the U.S. administration imposed tariffs up to 3,521% on solar imports from Southeast Asia. 
<h1 class="wp-block-heading">S&amp;P 500&#8217;s Top 5 Gainers</h1>
<figure class="wp-block-table"> 
<table>
<thead>
<tr>
<th>Company</th>
<th>% Change</th>
</tr>
</thead>
<tbody>
<tr>
<td>Equifax Inc. </td>
<td>14.34%</td>
</tr>
<tr>
<td>First Solar, Inc. </td>
<td>12.35%</td>
</tr>
<tr>
<td>Pentair plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>)</td>
<td>9.59%</td>
</tr>
<tr>
<td>Invesco Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVZ#NYSE">IVZ</a>)</td>
<td>9.17%</td>
</tr>
<tr>
<td>PulteGroup, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>)</td>
<td>8.30%</td>
</tr>
</tbody>
</table>
</figure>
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44926902/imf-slashes-us-growth-outlook-as-trump-tariffs-bite-raises-recession-odds-to-40">IMF Slashes US Growth Outlook As Trump Tariffs Bite, Raises Recession Odds To 40%</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Government

Large Cap

Macro Economic Events

Mid Cap

Broad U.S. Equity ETFs

Commodities

Econ #s

Economics

Federal Reserve

ETFs

$BTC

$ETH

SPDR Dow Jones Industrial Average ETF Trust

FSLR

Select Sector SPDR-Consumer Discretionary

Wall Street Rebounds Ahead Of Tesla Earnings, Dow Adds 1,000 Points, Bitcoin Hits $91,000: What's Driving Markets Tuesday?

U.S. stocks were higher, with the Dow Jones index gaining around 600 points on Tuesday.
Shares of Quest Diagnostics Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) rose sharply during Tuesday's session following <a href="https://www.benzinga.com/quote/DGX/earnings">better-than-expected first-quarter earnings.</a>
Quest Diagnostics reported quarterly earnings of $2.21 per share which beat the analyst consensus estimate of $2.15 per share. The company reported quarterly sales of $2.65 billion which beat the analyst consensus estimate of $2.63 billion.
Quest Diagnostics shares jumped 7.3% to $173.60 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) gained 15% to $6.39. PureCycle announced the sale of approximately $30 million in revenue bonds.</li>
<li>Hesai Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) shares jumped 15% to $13.36. Hesai introduced Infinity Eye, which will be available in three tailored versions A, B, and C. Each one caters to different levels of autonomous driving from basic assisted features to full automation.</li>
<li>NovaGold Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NG#NYSE">NG</a>) gained 14.7% to $3.5697 after the company and Paulson Advisers agreed to acquire Barrick&#8217;s 50% stake in Donlin Gold, forming a new partnership to develop the project.</li>
<li>Cipher Mining Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) surged 14.5% to $2.68.</li>
<li>First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) gained 13.7% to $139.15 after the US finalized plans to impose tariffs on most solar cells imported from Southeast Asia.</li>
<li>SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) jumped 13.6% to $13.74. SolarEdge Technologies will report financial results for the first quarter, before market open on Tuesday, May 6.</li>
<li>Webull Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>) shares rose 13.5% to $27.97.</li>
<li>Calix, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) jumped 13.1% to $37.59 after the company reported better-than-expected first-quarter financial results and issued second-quarter guidance above estimates. Additionally, the company announced an authorized increase to its stock repurchase program.</li>
<li>Bitdeer Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) jumped 12.2% to $8.52.</li>
<li>Riot Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) gained 11.1% to $6.99.</li>
<li>Equifax Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) gained 11% to $238.84 after the company reported better-than-expected first-quarter financial results. The company also authorized a $3 billion buyback and raised is dividend.</li>
<li>Seres Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) gained 10.5% to $8.27.</li>
<li>Akso Health Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHG#NASDAQ">AHG</a>) gained 8.8% to $1.22.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) rose 8.8% to $213.04.</li>
<li>Pentair plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>) climbed 7.3% to $84.70 after the company reported first-quarter financial results and beat its adjusted EPS and revenue estimates.</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) shares gained 6.8% to $134.63 after the company reported better-than-expected first-quarter financial results.</li>
<li>Danaher Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) rose 5.8% to $195.64 after the company reported better-than-expected first-quarter EPS and revenue.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44922024/how-to-earn-500-a-month-from-philip-morris-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Philip Morris Stock Ahead Of Q1 Earnings</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

BTDR

BULL

CALX

CIFR

CVNA

HSAI

MCRB

RIOT

SEDG

Quest Diagnostics Posts Better-Than-Expected Earnings, Joins Pentair, 3M, Danaher And Other Big Stocks Moving Higher On Tuesday

WIIM

Equifax shares are trading higher after the company reported better-than-expected Q1 financial results. The company also authorized a $3 billion buyback and raised is dividend.

Equifax Sees FY25 Revenues Between $5.91B-$6.03B Vs. $5.96B Estimate (Prior View: $5.890B-$6.01B), Sees Adjusted EPS Between $7.25-$7.65 Vs. $7.48 Estimate

Equifax Sees Q2 Revenues Between $1.495B-$1.525B (estimate: $1.50B), Adjusted EPS Between $1.85-$1.95 (estimate: $1.89)

Equifax Authorizes New $3B Share Repurchase Program And 28% Dividend Increase To $0.50 Per Share

Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) reported quarterly earnings of $1.53 per share which beat the analyst consensus estimate of $1.40 by 9.29 percent. This is a 2 percent increase over earnings of $1.50 per share from the same period last year. The company reported quarterly sales of $1.44 billion which beat the analyst consensus estimate of $1.42 billion by 1.55 percent. This is a 3.82 percent increase over sales of $1.39 billion the same period last year.

Earnings Beats

Equifax Q1 Adj EPS $1.53 Beats $1.40 Estimate, Sales $1.44B Beat $1.42B Estimate

Fintech

Press Releases

Equifax Introduces First-in-Market Mortgage Solution that Delivers Credit Report Alongside Employment Status from The Work Number®

Equifax Releases 2024 Security Annual Report

Equifax Announces Earnings Release Date and Conference Call for First Quarter 2025 Results

Equifax Releases 2024 Global Consumer Credit Trends Report

Equifax Delivers Above Guidance First Quarter Results; Authorizes New $3 Billion Share Repurchase Program and 28% Dividend Increase

Equifax Announces Participation in May Investor Conferences

Equifax 2025 Investor Day in New York City on June 17

Equifax Introduces myEquifax™ Mobile Application To Help Consumers Better Monitor Their Financial Health

Comments

Equifax

뉴스

에 대한 최신 뉴스 Equifax (NYSE:EFX) 주식

월요일, 2월 17, 2025

월요일, 4월 22, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌